DENTSPLY SIRONA (NASDAQ:XRAY) Posts Earnings Results, Misses Estimates By $0.08 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) posted its quarterly earnings results on Thursday. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08), Zacks reports. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. During the same quarter in the previous year, the company posted $0.50 EPS. The firm’s revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA updated its FY 2025 guidance to 1.600-1.600 EPS.

DENTSPLY SIRONA Trading Up 0.4%

NASDAQ XRAY traded up $0.04 on Friday, hitting $11.06. The company’s stock had a trading volume of 4,400,827 shares, compared to its average volume of 3,057,573. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The company’s 50-day simple moving average is $13.04 and its 200 day simple moving average is $14.48. The firm has a market cap of $2.21 billion, a P/E ratio of -2.34, a PEG ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA has a 52-week low of $10.69 and a 52-week high of $20.59.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently modified their holdings of XRAY. AQR Capital Management LLC lifted its holdings in DENTSPLY SIRONA by 109.8% in the second quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after buying an additional 6,970,086 shares during the period. Goldman Sachs Group Inc. raised its position in shares of DENTSPLY SIRONA by 827.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock worth $36,378,000 after acquiring an additional 2,172,343 shares in the last quarter. Qube Research & Technologies Ltd raised its position in shares of DENTSPLY SIRONA by 28.7% in the 2nd quarter. Qube Research & Technologies Ltd now owns 2,044,651 shares of the medical instruments supplier’s stock worth $32,469,000 after acquiring an additional 456,324 shares in the last quarter. Ieq Capital LLC lifted its stake in shares of DENTSPLY SIRONA by 158.8% in the 2nd quarter. Ieq Capital LLC now owns 632,520 shares of the medical instruments supplier’s stock valued at $10,044,000 after purchasing an additional 388,078 shares during the period. Finally, State Street Corp boosted its position in shares of DENTSPLY SIRONA by 5.5% during the second quarter. State Street Corp now owns 7,099,906 shares of the medical instruments supplier’s stock valued at $113,868,000 after purchasing an additional 369,876 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the subject of a number of research reports. Wells Fargo & Company cut their target price on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research report on Friday. Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a report on Thursday. Finally, Mizuho set a $13.00 price objective on DENTSPLY SIRONA in a report on Friday. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $16.42.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.